These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 19027242)
1. Pigmentation genes link Parkinson's disease to melanoma, opening a window on both etiologies. Herrero Hernández E Med Hypotheses; 2009 Mar; 72(3):280-4. PubMed ID: 19027242 [TBL] [Abstract][Full Text] [Related]
2. Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature. Zanetti R; Loria D; Rosso S Melanoma Res; 2006 Jun; 16(3):201-6. PubMed ID: 16718266 [TBL] [Abstract][Full Text] [Related]
3. On the track of the white tiger: pigmentation could be linked to prion diseases, and location explains why. Herrero Hernández E Med Hypotheses; 2009 Sep; 73(3):309-11. PubMed ID: 19423237 [TBL] [Abstract][Full Text] [Related]
4. Are Parkinson disease patients protected from some but not all cancers? Inzelberg R; Jankovic J Neurology; 2007 Oct; 69(15):1542-50. PubMed ID: 17699801 [TBL] [Abstract][Full Text] [Related]
5. Parkinson's Disease and Melanoma: Co-Occurrence and Mechanisms. Bose A; Petsko GA; Eliezer D J Parkinsons Dis; 2018; 8(3):385-398. PubMed ID: 29991141 [TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease, levodopa-use and the risk of melanoma. Vermeij JD; Winogrodzka A; Trip J; Weber WE Parkinsonism Relat Disord; 2009 Sep; 15(8):551-3. PubMed ID: 19501540 [TBL] [Abstract][Full Text] [Related]
7. Pigmentation as a clue to understanding Parkinson's disease and melanoma. Herrero Hernández E Ann Neurol; 2009 Jun; 65(6):759; author reply 759. PubMed ID: 19557863 [No Abstract] [Full Text] [Related]
9. A critical review of the function of neuromelanin and an attempt to provide a unified theory. Nicolaus BJ Med Hypotheses; 2005; 65(4):791-6. PubMed ID: 15949901 [TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease and family history. Sellbach AN; Boyle RS; Silburn PA; Mellick GD Parkinsonism Relat Disord; 2006 Oct; 12(7):399-409. PubMed ID: 16797215 [TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease and cancer: insights for pathogenesis from epidemiology . D'Amelio M; Ragonese P; Sconzo G; Aridon P; Savettieri G Ann N Y Acad Sci; 2009 Feb; 1155():324-34. PubMed ID: 19250224 [TBL] [Abstract][Full Text] [Related]
13. Epidemiologic studies of environmental exposures in Parkinson's disease. Elbaz A; Tranchant C J Neurol Sci; 2007 Nov; 262(1-2):37-44. PubMed ID: 17673256 [TBL] [Abstract][Full Text] [Related]
14. Melanin and Neuromelanin Fluorescence Studies Focusing on Parkinson's Disease and Its Inherent Risk for Melanoma. Leupold D; Szyc L; Stankovic G; Strobel S; Völker HU; Fleck U; Müller T; Scholz M; Riederer P; Monoranu CM Cells; 2019 Jun; 8(6):. PubMed ID: 31208049 [TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease. Hatano T; Kubo S; Sato S; Hattori N J Neurochem; 2009 Dec; 111(5):1075-93. PubMed ID: 19780902 [TBL] [Abstract][Full Text] [Related]
16. The association between Parkinson's disease and melanoma. Pan T; Li X; Jankovic J Int J Cancer; 2011 May; 128(10):2251-60. PubMed ID: 21207412 [TBL] [Abstract][Full Text] [Related]
17. The genetics of melanoma. Bishop JN; Harland M; Bishop DT Br J Hosp Med (Lond); 2006 Jun; 67(6):299-304. PubMed ID: 16821732 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease. Dong J; Gao J; Nalls M; Gao X; Huang X; Han J; Singleton AB; Chen H; Neurobiol Aging; 2014 Jun; 35(6):1512.e5-1512.e10. PubMed ID: 24439955 [TBL] [Abstract][Full Text] [Related]